why choose us

Clinical Trials Search

Showing 15,970 of 132,656 result(s)
Robotic vs. Open NSM for Early Stage Breast Cancer

Status: Completed

Condition: Breast Cancer Female

Interventions: Robotic-assisted Nipple sparing mastectomy procedures

Date: 2023-01-17

Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)

Status: Completed

Condition: Breast Cancer

Interventions: Fitbit wearable device, home exercise sessions, and telehealth appointments with physical therapist.

Date: 2023-01-17

Personalized Mobile Cognitive Behavioral Therapy Application

Status: NOT_YET_RECRUITING

Condition: Anxiety Disorders and Symptoms

Interventions: All new material in the personalized condition will be introduced within the first four weeks and will contain modules targeting participant's pe

Date: 2023-01-17

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed;Refractory CD19 Positive ALL and NHL

Status: NOT_YET_RECRUITING

Condition: Acute Lymphoblastic Leukemia, in Relapse

Interventions: Infusion of CD19 CAR-T Cells manufactured on-site using the CliniMACS Prodigy

Date: 2023-01-17

The Effect of Sulfasalazine on CRH Levels in Pregnant Women

Status: Completed

Condition: Preterm Birth

Interventions: Sulfasalazine will be administered between 24 and 36 weeks of pregnancy

Date: 2023-01-17

Drug Screening Using Novel IMD in Renal Cell Carcinoma

Status: Completed

Condition: Renal Cell Carcinoma

Interventions:

Small, implantable device with 20 microreservoirs for drug and drug combinations, via needle, percutaneously, and guided by interventional radiolog

Date: 2023-01-17

The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention

Status: Completed

Condition: Postpartum Depression

Interventions: Evidence-based 5 session psychosocial intervention that has been found to prevent ~50% of postpartum depression among low-income, at risk women.

Date: 2023-01-17

An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy

Status: Completed

Condition: HIV Infections

Interventions: Patients will receive an interactive PrEP Educational Tool.
This interactive tool will be securely sent via the patient portal.
After loggin

Date: 2023-01-17

Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products

Status: Completed

Condition: Relapsed Hematologic Malignancy

Interventions:

Date: 2023-01-17